184 related articles for article (PubMed ID: 17068487)
1. A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy.
Xu YF; Zhu LP; Hu B; Fu GF; Zhang HY; Wang JJ; Xu GX
Cancer Gene Ther; 2007 Feb; 14(2):151-7. PubMed ID: 17068487
[TBL] [Abstract][Full Text] [Related]
2. Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth.
Hu B; Kou L; Li C; Zhu LP; Fan YR; Wu ZW; Wang JJ; Xu GX
Cancer Gene Ther; 2009 Aug; 16(8):655-63. PubMed ID: 19229287
[TBL] [Abstract][Full Text] [Related]
3. Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer.
Fu GF; Li X; Hou YY; Fan YR; Liu WH; Xu GX
Cancer Gene Ther; 2005 Feb; 12(2):133-40. PubMed ID: 15565182
[TBL] [Abstract][Full Text] [Related]
4. Sequence analysis of two cryptic plasmids from Bifidobacterium longum DJO10A and construction of a shuttle cloning vector.
Lee JH; O'Sullivan DJ
Appl Environ Microbiol; 2006 Jan; 72(1):527-35. PubMed ID: 16391088
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of Bifidobacterium longum-mediated human granulocyte colony-stimulating factor and/or endostatin combined with cyclophosphamide in mouse-transplanted tumors.
Zhu LP; Yin Y; Xing J; Li C; Kou L; Hu B; Wu ZW; Wang JJ; Xu GX
Cancer Sci; 2009 Oct; 100(10):1986-90. PubMed ID: 19678823
[TBL] [Abstract][Full Text] [Related]
6. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth.
Li X; Fu GF; Fan YR; Liu WH; Liu XJ; Wang JJ; Xu GX
Cancer Gene Ther; 2003 Feb; 10(2):105-11. PubMed ID: 12536198
[TBL] [Abstract][Full Text] [Related]
7. [Construction of Escherichia coli-Bifidobacterium longum shuttle vector and expression of tumor suppressor gene PTEN in B. longum].
Hou X; Liu JE
Wei Sheng Wu Xue Bao; 2006 Jun; 46(3):347-52. PubMed ID: 16933599
[TBL] [Abstract][Full Text] [Related]
8. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors.
Yazawa K; Fujimori M; Amano J; Kano Y; Taniguchi S
Cancer Gene Ther; 2000 Feb; 7(2):269-74. PubMed ID: 10770636
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of Bifidobacterium longum-mediated human interleukin-2 with endostatin or TRAIL in transplanted tumors in mice.
Yin Y; Kou L; Wang JJ; Xu GX
Exp Ther Med; 2012 Mar; 3(3):481-486. PubMed ID: 22969915
[TBL] [Abstract][Full Text] [Related]
10. Transformation of Bifidobacterium longum with pRM2, a constructed Escherichia coli-B. longum shuttle vector.
Missich R; Sgorbati B; LeBlanc DJ
Plasmid; 1994 Sep; 32(2):208-11. PubMed ID: 7846144
[TBL] [Abstract][Full Text] [Related]
11. Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice.
Long RT; Zeng WS; Chen LY; Guo J; Lin YZ; Huang QS; Luo SQ
Int J Obes (Lond); 2010 Apr; 34(4):712-9. PubMed ID: 20065960
[TBL] [Abstract][Full Text] [Related]
12. Construction of a reporter vector for the analysis of Bifidobacterium longum promoters.
Klijn A; Moine D; Delley M; Mercenier A; Arigoni F; Pridmore RD
Appl Environ Microbiol; 2006 Nov; 72(11):7401-5. PubMed ID: 16997985
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of Bifidobacterium longum biovar longum NAL8 plasmids and construction of a novel replicon screening system.
Guglielmetti S; Karp M; Mora D; Tamagnini I; Parini C
Appl Microbiol Biotechnol; 2007 Apr; 74(5):1053-61. PubMed ID: 17151871
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an insertion sequence-like element, ISBlo15, identified in a size-increased cryptic plasmid pBK283 in Bifidobacterium longum BK28.
Fukiya S; Sugiyama T; Kano Y; Yokota A
J Biosci Bioeng; 2010 Aug; 110(2):141-6. PubMed ID: 20547379
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of three plasmids from Bifidobacterium longum.
Corneau N; Emond E; LaPointe G
Plasmid; 2004 Mar; 51(2):87-100. PubMed ID: 15003705
[TBL] [Abstract][Full Text] [Related]
16. Proposal to reclassify the three biotypes of Bifidobacterium longum as three subspecies: Bifidobacterium longum subsp. longum subsp. nov., Bifidobacterium longum subsp. infantis comb. nov. and Bifidobacterium longum subsp. suis comb. nov.
Mattarelli P; Bonaparte C; Pot B; Biavati B
Int J Syst Evol Microbiol; 2008 Apr; 58(Pt 4):767-72. PubMed ID: 18398167
[TBL] [Abstract][Full Text] [Related]
17. A targeted gene knockout method using a newly constructed temperature-sensitive plasmid mediated homologous recombination in Bifidobacterium longum.
Sakaguchi K; He J; Tani S; Kano Y; Suzuki T
Appl Microbiol Biotechnol; 2012 Jul; 95(2):499-509. PubMed ID: 22639142
[TBL] [Abstract][Full Text] [Related]
18. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
19. Characterization of plasmids from human infant Bifidobacterium strains: sequence analysis and construction of E. coli-Bifidobacterium shuttle vectors.
Shkoporov AN; Efimov BA; Khokhlova EV; Steele JL; Kafarskaia LI; Smeianov VV
Plasmid; 2008 Sep; 60(2):136-48. PubMed ID: 18652842
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the plasmid pMB1 from Bifidobacterium longum and its use for shuttle vector construction.
Rossi M; Brigidi P; Gonzalez Vara y Rodriguez A; Matteuzzi D
Res Microbiol; 1996; 147(3):133-43. PubMed ID: 8761732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
